PLANNING COMMITTEE

Dr. Wendy Lam, B Sc. (Pharm), MD, FRCPC

Hematologist and Medical Oncologist
Burnaby Hospital Regional Cancer Center
Director, BC Community Oncology Trialists
Burnaby, BC

Dr. Wendy Lam is a hematologist and medical oncologist at the Burnaby Hospital Regional Cancer Centre.

She received her B.Sc (Pharmacy) at Dalhousie University and her MD from University of British Columbia. She then completed her Internal Medicine residency at UBC and Hematology fellowship at McMaster University.

She is the Founding Director of the British Columbia Community Oncology Trialists (BC Cot), which is a collaborative group of oncologists and hematologists involved in clinical research.

Her other interests include education of patients through meeting with patient groups. She has also been instrumental in organizing meetings for continued medical education.

She is Director of the Society of Hematology and Oncology of BC at British Columbia Medical Association

Dr. Laurie H. Sehn, MD, MPH

Clinical Professor
Centre for Lymphoid Cancer,
British Columbia Cancer Agency and
University of British Columbia,
Vancouver, BC

Dr. Laurie Sehn is currently Clinical Professor with the British Columbia Cancer Agency and University of British Columbia, Canada. She has been a medical oncologist and clinical investigator at the BC Cancer Agency since 1998, and is currently the Chair of the Lymphoma Tumour Group. Dr. Sehn graduated from McGill Medical School, Montreal, Canada and received her training in Internal Medicine at Columbia Presbyterian Medical Center, Columbia University, New York, USA. She was trained in Haematology-Oncology at the Dana-Farber Cancer Institute and Brigham and Women’s Hospital, Harvard University, Boston, and received a Masters of Public Health degree from Harvard School of Public Health, Harvard University. Prior to returning to Canada, she spent a year at the Dana-Farber Cancer Institute attending on the Bone Marrow Transplant service. Dr. Sehn is Chair of the medical advisory board for the International Lymphoma Coalition. She has also served as a member of the editorial board of Journal of Clinical Oncology and Leukemia Lymphoma, and is currently an Associate Editor for Blood. Dr. Sehn also serves as co-chair of the Lymphoma Site of the Canadian Cancer Trials Group.

Dr. Anca Prica,

Assistant Professor, University of Toronto
Division of Medical Oncology and Hematology
Department of Medicine
Hematologist, Princess Margaret Cancer Centre
University Health Network

Dr. Darrell White, MD, FRCPC

Senior Associate Dean,
Faculty of Medicine,
Professor, Department of Medicine
Dalhousie University, Halifax, NS

Darrell White is a Professor of Medicine and Senior Associate Dean, Faculty of Medicine, Dalhousie University and a hematologist at the Queen Elizabeth II Health Sciences Centre, Halifax, Nova Scotia, Canada. He is a graduate of Dalhousie Medical School, trained in Internal Medicine at the University of Western Ontario and Hematology at Dalhousie. He completed a fellowship at the Myeloma and Transplantation Research Center at the University of Arkansas. He has completed graduate studies in Community Health and Epidemiology at Dalhousie.

Since 1998 he has been a member of the Division of Hematology, Department of Medicine at the Queen Elizabeth II Health Sciences Center in Halifax. His research interest and clinical practice focus on transplant and non-transplant treatment of multiple myeloma. He is a member of the Myeloma Sub-Committee of the Canadian Trials Group and is Chair of the Board of the Myeloma Canada Research Network (MCRN). His administrative experience includes being past program director for adult hematology and core internal medicine. He is an examiner for the Royal College of Physicians and Surgeons of Canada for Hematology and Internal Medicine and is Past-Chair of the Royal College Specialty Committee for Hematology.

Dr. Nathalie Johnson,

Associate Professor – Department of Medicine,
Division of Experimental Medicine
McGill University, Montreal, QC

Dr. Johnson completed her training at McGill University as a Hematologist and Oncologist. Having recently returned to Montreal from her five-year research training at the British Columbia Cancer Agency in Vancouver, , Dr. Johnson’s research focuses on determining the genetic abnormalities that are associated with a poor response to chemotherapy in lymphoma,, especially in adolescent and young adults patients.

Dr. Pamela Skrabek, MD, MSc, FRCPC

Chair Lymphoproliferative Disease Site Group
Hematologist at CancerCare Manitoba
Winnipeg Manitoba

Dr. Pamela Skrabek is hematologist who completed medical school and residencies in Internal Medicine and Haematology at the University of Manitoba. Subsequently she received a Manitoba Health Research Council Clinical Research Fellowship award and completed additional training in lymphoma. She has completing a Master of Science in Community Health Sciences with a thesis project examining patient and system factors resulting in delays in diagnosis and treatment of lymphoma. As chair of the provincial Lymphoproliferative Disease Site Group (DSG) she provides leadership and coordination for DSG multidisciplinary clinics, teaching and educational, administrative and research activities. She is also site Medical Director of Buhler Cancer Centre at Victoria General Hospital.

Dr. Irwindeep Sandhu,

Associate Professor
Department of Medicine
Division of Hematology (DoM)
University of Alberta, Edmonton, AB

Dr. Irwindeep Sandhu is currently appointed as Associate Professor in the Division of Hematology (DoM) in the Faculty of Medicine and Dentistry.

Dr. Carolyn Owen, MD, FRCPC

Associate Professor
Tom Baker Cancer Centre, Calgary, AB

Dr. Owen’s previous research has focused largely on the molecular basis of familial MDS and AML and she continues to investigate families with inherited hematological malignancies.  Despite her research interest in myeloid neoplasms, her clinical work is focused on lymphoma and chronic lymphocytic leukemia and she has a research focus on clinical trials with significant national leadership in CLL clinical trials.

PLANNING COMMITTEE / ALLIED HEALTH SESSIONS

Nanette Cox-Kennett, BsCN, MN, NP

Cross Cancer Institute
Edmonton, AB

Nan has been working in oncology for longer than she cares to remember. She has previously been a staff nurse, patient educator, staff educator and since 2005 as Nurse Practitioner for the Hematology and Bone Marrow Transplant Program at the Cross Cancer Institute. Primary interests are: CLL, stem cell collection and cardio-oncology survivorship concerns post transplant.

Nikki Blosser, BSc. Pharm, ACPR

Clinical Pharmacist, Blood and Marrow Transplant Clinic
Tom Baker Cancer Centre

Nikki graduated from Memorial University of Newfoundland School of Pharmacy in 2010 and then moved to Calgary to complete an Accredited Canadian Residency Program with a focus in oncology. For the past eight years she has been working as a clinical pharmacist in the Blood and Marrow Transplant Program at the Tom Baker Cancer Centre. Nikki continues to precept Cancer Care pharmacy residents in their BMT rotations. She obtained her Advanced Prescribing Authority (APA) in 2013 and helped implement the pharmacist-led therapeutic drug monitoring role in the BMT clinic. She is currently serving as the interim Clinical Research Pharmacist in the Hematology/Oncology/Transplant Program at Alberta Children’s Hospital.

Michelle Forman, RN, CON(C)

Burnaby Cancer Centre
Burnaby, BC

Michelle has been nursing for 26 years, and has spent her entire career working at Burnaby Hospital, B.C. Michelle worked in a variety of settings, including acute medicine, discharge planning, and IV therapy, before settling in to the outpatient Oncology Clinic in 1995.

The community clinic is comprised of two hematologist oncologists and one medical oncologist, as well as a dedicated team of allied health professionals who treat a wide variety of patients and tumor types. Michelle is actively involved in staff education, patient teaching, chemotherapy administration, clinical trials, as well as symptom and side effect management.

Michelle is passionate about oncology nursing and feels that her knowledge and experience play an integral role in helping to provide for the physical and emotional patient care needs. Michelle has also enjoyed the opportunity to be involved in many initiatives aimed at enhancing the cancer patients experience as well as the educational needs of fellow oncology health care professionals.

She is also a founding member and ongoing member of the organizing committee for the NACCC conference, an annual provincial conference in Oncology Nursing.